Clinical Trial: Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers
Sponsor and Collaborators
AVEO Pharmaceuticals, Inc.
Contact: Ferry Eskens, MD, PhD
+31 (10) 463-4897
Contact: Elisabeth de Vries, MD
+31 (50) 361 28 21
Ferry Eskens, MD, PhD Erasmus Medical Center; Department of Medical Oncology
Next post in Gastrointestinal Cancer Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.